Neuroblastoma Signs And Symptoms Checker

Neuroblastoma Signs & Symptoms Checker | DoseWay

Neuroblastoma Signs & Symptoms Checker

Assess potential indicators of neuroblastoma based on clinical presentation

Important: This tool is for informational purposes only and does not provide medical advice. It is not a substitute for professional medical evaluation. Always consult a qualified healthcare provider for diagnosis and treatment.

Patient Information

Select Gender Male Female Rather not say

Common Symptoms

0%

Specific Signs

Additional Indicators

Less than 2 weeks 2-4 weeks 1-3 months Over 3 months

Assessment Results

Neuroblastoma Risk Score

0
Low Risk Moderate Risk High Risk

Interpretation

Based on the information provided, your risk level will appear here after calculation.

Recommendations

Recommendations will be provided based on your calculated risk score.

This tool is provided for educational purposes only. It does not provide medical advice.

© 2023 DoseWay Medical Resources | support@doseway.com | WhatsApp: +92318-6144650

// Initialize slider values document.addEventListener(‘DOMContentLoaded’, function() { const weightLossSlider = document.getElementById(‘weightLoss’); const weightLossValue = document.getElementById(‘weightLossValue’); weightLossSlider.addEventListener(‘input’, function() { weightLossValue.textContent = this.value; }); // Initialize social sharing initSocialSharing(); }); // Calculate button handler document.getElementById(‘calculateBtn’).addEventListener(‘click’, calculateScore); function calculateScore() { // Get form values const name = document.getElementById(‘name’).value; const age = document.getElementById(‘age’).value; // Validate required fields if (!name || !age) { alert(‘Please fill in all required fields (Name and Age)’); return; } // Calculate score based on inputs (simplified for demo) let score = 0; // Add points for abdominal mass const abdominalMass = document.querySelector(‘input[name=”abdominalMass”]:checked’).value; if (abdominalMass === ‘mild’) score += 10; if (abdominalMass === ‘moderate’) score += 20; if (abdominalMass === ‘severe’) score += 30; // Add points for bone pain const bonePain = document.querySelector(‘input[name=”bonePain”]:checked’).value; if (bonePain === ‘intermittent’) score += 5; if (bonePain === ‘persistent’) score += 15; // Add points for fever const fever = document.querySelector(‘input[name=”fever”]:checked’).value; if (fever === ‘low’) score += 5; if (fever === ‘high’) score += 10; // Add points for weight loss const weightLoss = parseInt(document.getElementById(‘weightLoss’).value); if (weightLoss > 5) score += weightLoss; // Add points for specific signs const raccoonEyes = document.querySelector(‘input[name=”raccoonEyes”]:checked’).value; if (raccoonEyes !== ‘absent’) score += 25; const proptosis = document.querySelector(‘input[name=”proptosis”]:checked’).value; if (proptosis !== ‘absent’) score += 20; const opsoclonus = document.querySelector(‘input[name=”opsoclonus”]:checked’).value; if (opsoclonus === ‘present’) score += 30; const horners = document.querySelector(‘input[name=”horners”]:checked’).value; if (horners === ‘present’) score += 15; // Add points for each additional symptom const symptoms = document.querySelectorAll(‘input[name=”symptoms”]:checked’); score += symptoms.length * 5; // Add points for duration const duration = document.getElementById(‘duration’).value; if (duration === ‘1-3’) score += 10; if (duration === ‘over3’) score += 5; // Cap score at 100 score = Math.min(score, 100); // Display results document.getElementById(‘scoreValue’).textContent = score; // Position risk indicator const indicator = document.getElementById(‘riskIndicator’); indicator.style.left = `${score}%`; // Set interpretation and recommendations based on score const interpretationText = document.getElementById(‘interpretationText’); const recommendationsText = document.getElementById(‘recommendationsText’); const riskCategory = document.getElementById(‘riskCategory’); if (score < 20) { riskCategory.innerHTML = 'LOW RISK – Unlikely to indicate neuroblastoma’; interpretationText.innerHTML = ‘Based on the information provided, the symptoms and signs do not strongly suggest neuroblastoma. However, continue to monitor the situation and consult a healthcare provider if symptoms persist or worsen.’; recommendationsText.innerHTML = ‘
  • Continue to monitor for any new or worsening symptoms
  • Maintain regular pediatric check-ups
  • Contact a healthcare provider if symptoms persist beyond 2 weeks
‘; } else if (score < 50) { riskCategory.innerHTML = 'MODERATE RISK – Some indicators present’; interpretationText.innerHTML = ‘The symptoms and signs reported show some characteristics that could be associated with neuroblastoma. Further evaluation is recommended to rule out this condition.’; recommendationsText.innerHTML = ‘
  • Schedule an appointment with a pediatrician within the next week
  • Consider requesting urine catecholamine tests (VMA/HVA)
  • Monitor symptoms daily and note any changes
  • If abdominal mass is present, request ultrasound examination
‘; } else { riskCategory.innerHTML = ‘HIGH RISK – Strong indicators present’; interpretationText.innerHTML = ‘The combination of symptoms and signs reported is concerning for possible neuroblastoma. Prompt medical evaluation is strongly recommended.’; recommendationsText.innerHTML = ‘
  • Seek immediate medical evaluation with a pediatric oncologist
  • Request urgent ultrasound or CT scan of the abdomen
  • Complete blood count (CBC) and urine catecholamine tests needed
  • Consider bone marrow examination if indicated
  • Do not delay evaluation – early diagnosis improves outcomes
‘; } // Show results section document.getElementById(‘resultsSection’).style.display = ‘block’; // Initialize PDF button document.getElementById(‘pdfBtn’).addEventListener(‘click’, generatePDF); } function initSocialSharing() { const pageUrl = encodeURIComponent(window.location.href); const pageTitle = encodeURIComponent(‘Neuroblastoma Risk Assessment Results’); // Set Facebook share URL document.querySelector(‘.facebook’).href = `https://www.facebook.com/sharer/sharer.php?u=${pageUrl}`; // Set Twitter share URL const twitterText = encodeURIComponent(‘Check out my Neuroblastoma Risk Assessment results from DoseWay’); document.querySelector(‘.twitter’).href = `https://twitter.com/intent/tweet?text=${twitterText}&url=${pageUrl}`; // Set LinkedIn share URL const linkedinText = encodeURIComponent(‘Neuroblastoma Risk Assessment Results’); document.querySelector(‘.linkedin’).href = `https://www.linkedin.com/shareArticle?mini=true&url=${pageUrl}&title=${linkedinText}`; // Set WhatsApp share URL const whatsappText = encodeURIComponent(`Check out my Neuroblastoma Risk Assessment results: ${pageUrl}`); document.querySelector(‘.whatsapp’).href = `https://api.whatsapp.com/send?text=${whatsappText}`; } function generatePDF() { // Use jsPDF to generate report const { jsPDF } = window.jspdf; const doc = new jsPDF(); // Add header doc.setFontSize(18); doc.setTextColor(26, 115, 232); doc.text(‘Neuroblastoma Assessment Report’, 105, 20, null, null, ‘center’); doc.setFontSize(10); doc.setTextColor(100); doc.text(‘Generated by DoseWay Medical Resources’, 105, 26, null, null, ‘center’); doc.text(‘https://doseway.com | support@doseway.com | WhatsApp: +92318-6144650’, 105, 30, null, null, ‘center’); // Add patient info doc.setFontSize(12); doc.setTextColor(0); doc.text(`Patient Name: ${document.getElementById(‘name’).value}`, 20, 40); doc.text(`Age: ${document.getElementById(‘age’).value} years`, 20, 46); doc.text(`Gender: ${document.getElementById(‘gender’).value || ‘Not specified’}`, 20, 52); // Add assessment date const now = new Date(); doc.text(`Assessment Date: ${now.toLocaleDateString()} ${now.toLocaleTimeString()}`, 20, 58); // Add score doc.setFontSize(14); doc.setTextColor(26, 115, 232); doc.text(‘Assessment Summary’, 20, 70); doc.setFontSize(36); const score = document.getElementById(‘scoreValue’).textContent; doc.text(`Score: ${score}`, 105, 80, null, null, ‘center’); doc.setFontSize(12); doc.setTextColor(0); doc.text(document.getElementById(‘riskCategory’).textContent, 105, 88, null, null, ‘center’); // Add interpretation doc.setFontSize(12); doc.text(‘Interpretation:’, 20, 100); doc.setFontSize(11); const interpretation = document.getElementById(‘interpretationText’).textContent; doc.text(interpretation, 20, 106, {maxWidth: 170}); // Add recommendations doc.setFontSize(12); doc.text(‘Recommendations:’, 20, 130); doc.setFontSize(11); const recommendations = document.getElementById(‘recommendationsText’).textContent; doc.text(recommendations, 20, 136, {maxWidth: 170}); // Add footer doc.setFontSize(10); doc.setTextColor(100); doc.text(‘This report is generated for informational purposes only and does not constitute medical advice.’, 105, 280, null, null, ‘center’); doc.text(‘© 2023 DoseWay Medical Resources | https://doseway.com’, 105, 285, null, null, ‘center’); // Save the PDF doc.save(`Neuroblastoma_Assessment_${document.getElementById(‘name’).value || ‘Patient’}.pdf`); }

Try More Free Tools:

Neuroblastoma Signs And Symptoms Checker

Neuroblastoma-Signs-And-Symptoms-Checker
Neuroblastoma-Signs-And-Symptoms-Checker

Neuroblastoma: Symptoms, Risk Factors, and Early Detection

Neuroblastoma is a rare but serious pediatric cancer that develops from immature nerve cells, primarily affecting infants and children under 5 years old. Early detection is crucial for improving survival rates, which is why recognizing neuroblastoma symptoms and understanding risk factors can make a significant difference in diagnosis and treatment.

Our Free Neuroblastoma Signs And Symptoms Checker helps parents and caregivers assess potential warning signs based on clinical symptoms. Below, we explain everything you need to know about neuroblastoma, how the calculator works, and what the results mean.

What Is Neuroblastoma?

Neuroblastoma is an embryonal tumor of the sympathetic nervous system, most commonly arising in the adrenal glands, abdomen, chest, or spine. It accounts for 6-10% of childhood cancers and is the most common cancer in infants.

Key Facts About Neuroblastoma Signs And Symptoms Checker

  • Most frequent age group: 0-5 years (90% of cases)
  • Common locations: Adrenal glands (40%), abdomen (30%), chest (20%)
  • Risk factors: Family history, genetic mutations (ALK, PHOX2B)
  • Survival rate: Varies by stage (90% for low-risk, <50% for high-risk metastatic cases)

Neuroblastoma Symptoms & Warning Signs

Symptoms vary depending on the tumor’s location and whether it has spread (metastasis). Our Neuroblastoma Signs And Symptoms Checker evaluates the following key indicators:

1. Common Symptoms

  • Abdominal mass or swelling (most frequent sign)
  • Bone pain (if cancer spreads to bones)
  • Unexplained fever (low-grade or persistent)
  • Weight loss & fatigue (due to metabolic changes)

2. Specific Clinical Signs

  • Periorbital ecchymosis (“Raccoon eyes”) – Bruising around the eyes
  • Proptosis (bulging eyes) – Due to orbital metastasis
  • Opsoclonus-myoclonus syndrome – Rapid, irregular eye movements
  • Horner’s syndrome – Drooping eyelid, pupil constriction (if a tumor affects the neck nerves)

3. Additional Indicators

  • Hypertension (from catecholamine secretion)
  • Diarrhea (due to vasoactive intestinal peptide secretion)
  • Leg weakness or paralysis (if spinal cord compression occurs)

How Our Neuroblastoma Signs And Symptoms Checker Works

Our tool evaluates symptoms and calculates a risk score based on clinical presentation. Here’s how it functions:

1. Input Fields & Scoring System

SymptomScoring Weight
Abdominal mass (severe)+30 points
Bone pain (persistent)+15 points
Raccoon eyes (bilateral)+25 points
Opsoclonus-myoclonus+30 points
Weight loss (>5%)+5-15 points
Table Input Fields & Scoring System

2. Risk Categories & Interpretation

Score RangeRisk LevelInterpretation
0-19Low RiskUnlikely neuroblastoma; monitor symptoms
20-49Moderate RiskFurther evaluation needed (ultrasound, urine tests)
50+High RiskUrgent medical consultation required
Table Risk Categories & Interpretation

3. Results & Recommendations

  • Low Risk: Continue monitoring; consult if symptoms worsen.
  • Moderate Risk: Schedule a pediatric visit; consider urine VMA/HVA tests.
  • High Risk: Seek immediate oncologist evaluation; imaging (CT/MRI) may be needed.

Why Early Detection Matters

Neuroblastoma Signs And Symptoms Checker prognosis depends heavily on stage at diagnosis:

Stage5-Year Survival Rate
Stage 1 (Localized)90%+
Stage 4 (Metastatic)40-50%
Table: Why Early Detection Matters

Early detection allows for less aggressive treatment (surgery only vs. chemotherapy/radiation).

Final Thoughts

Our Free Neuroblastoma Signs And Symptoms Checker helps parents and caregivers assess concerning symptoms and decide when to seek medical advice. While not a diagnostic tool, it provides valuable insights based on clinical risk factors.

If your child shows high-risk symptoms, consult a pediatric oncologist immediately. Early intervention significantly improves outcomes.

FAQs

Can neuroblastoma be detected before symptoms appear?

Some cases are found via prenatal ultrasound, but most are diagnosed after symptoms develop.

What tests confirm neuroblastoma?

Urine tests (VMA, HVA – catecholamine markers)
Imaging (Ultrasound, CT, MRI, MIBG scan)
Biopsy (Definitive diagnosis)

Is neuroblastoma hereditary?

Most cases are sporadic, but 1-2% are familial (linked to ALK or PHOX2B mutations).

Add a Comment

Your email address will not be published. Required fields are marked *